CARDINAL HEALTH’S LEADERSHIP IN DEVELOPING THE CIRCULAR HEALTHCARE ECONOMY IN AUSTRALIAN MEDICAL DEVICES
With
Neroli Manning,
Managing Director
Cardinal Health – Australia & New Zealand
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | May 2026
Neroli Manning is the Managing Director for Cardinal Health Australia & New Zealand (ANZ). With over 30 years of experience in the healthcare industry, Neroli is a transformative leader known for her people-first, customer-centric leadership style.
Her career spans Australia, New Zealand, and the Asia Pacific region, where she has held senior management roles in the medical device, capital equipment, and radiopharmaceutical sectors with global leaders like CR Bard, Medtronic, Philips, Abbott, and Sirtex.
Neroli’s leadership is defined by her ability to drive change, foster collaboration, and build high-performing teams. Additionally, having held a variety of senior commercial functional positions, she is able to leverage her deep experience and cross-functional insights to align teams, streamline operations, and deliver strategic outcomes. She is also passionate about mentoring emerging leaders and shaping the future of healthcare through inclusive, values-driven leadership.
As a founder of her own healthcare consulting firm, Neroli demonstrated entrepreneurial leadership, guiding global medical device companies through complex market challenges. Her legacy includes cultivating cultures of accountability, innovation, and continuous learning.
Beyond leading Cardinal Health’s operations in ANZ, Neroli also contributes to the broader industry as a company director and member of the Industry Policy Committee for the Medical Technology Association of Australia (MTAA).
Neroli has a Master’s of Business (Marketing) degree from the University of Technology, Sydney. In her spare time, she enjoys spending time with friends and family, exercising, working on her farm, travelling and playing golf.
Source: Supplied
-
Adjunct Professor Alanna Geary talks Nursing Leadership
Adjunct Professor Alanna Geary FACN,
Chief Nursing & Midwifery Officer,
Metro North Hospital Hospital & Health Service, Queensland
talks Nursing Leadership -
ICTD: Why negative results in clinical trials matter
To mark International Clinical Trials Day 2026, Australian Health Journal commences a 4 part special series leaving up to 20th May. Through conversations with leading researchers, clinicians and trial organisations, the series highlights achievements in the year that was for clinical trials.
Negative results in a clinical trial can be extremely valuable — both scientifically and ethically. A “negative result” usually means the treatment being tested did not work better than the standard treatment, placebo, or expected outcome.Negative results in a clinical trial can be extremely valuable — both scientifically and ethically. A “negative result” usually means the treatment being tested did not work better than the standard treatment, placebo, or expected outcome.
-
Outstanding Achievement
George FaithfullGeorge has been in the medical device industry in a variety of roles for over 35 years including Sales, Marketing, Business Development, General Management, R&D, Clinical, Regulatory and Government Affairs. He has worked for Stryker in Australia, USA and across Asia.
